Target intelligence / Profile preview

Host cell transcription machinery

Molecular classification
Other (multi-component macromolecular machinery), Enzyme (includes DNA-dependent RNA polymerase), Transcription factor (components), Chromatin remodeling complexes
01

Overview

The host cell transcription machinery refers to the collection of enzymes, protein complexes, and regulatory factors required for the transcription of DNA into RNA within eukaryotic cells, primarily DNA-dependent RNA polymerases (e.g., RNA polymerase II for mRNA synthesis), general transcription factors, mediator complexes, and chromatin-modifying enzymes[3][2]. This machinery is essential for gene expression and normal cellular function. Many viruses subvert or hijack the host transcription machinery to redirect the cell's resources for viral gene expression, often shutting off the production of host mRNAs[5][6]. Pharmacologically, targeting host transcription machinery is non-specific and generally cytotoxic, as it affects gene expression globally. However, certain drugs and toxins (e.g., actinomycin D, α-amanitin) and experimental modulators of chromatin structure can inhibit or modulate transcription. Altered transcriptional activity is implicated in various diseases, including viral infections (which exploit these enzymes), cancers (where transcription may be dysregulated), and other conditions involving aberrant gene expression[2][6][3].

Other names
Host transcription machineryCellular transcription machineryHost RNA polymerase complexesTranscriptional apparatus
02

Mechanism of action

Inhibition of RNA polymerase, Inhibition of transcription factor binding or function, Chromatin modification, Viral hijacking or suppression of host mRNA synthesis

03

Biological functions

TranscriptionGene expression regulationmRNA synthesisDNA-dependent RNA polymerizationChromatin modification
04

Disease associations

Infection (viral infection)Cancer (dysregulated transcription)Neurodegenerative disease (dysregulated gene expression)Other
05

Safety considerations

Broad suppression of transcription is generally cytotoxic (affects all gene expression)risk of severe off-target effectstissue-specific toxicity (especially in dividing/proliferative tissues such as gut, bone marrow)risk of immunosuppression
06

Interacting drugs

Actinomycin D

4 more in the full profile.

07

Biomarkers

RNA polymerase subunit levels or activity (e.g., POLR2A)transcription factor levels (e.g., p53, MYC)chromatin marks (e.g., histone acetylation status)global mRNA expression profiles

Beyond the preview

Go deeper on Host cell transcription machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell transcription machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call